Plasmid DNA vaccines: Tissue distribution and effects of DNA sequence, adjuvants and delivery method on integration into host DNA

Citation
S. Manam et al., Plasmid DNA vaccines: Tissue distribution and effects of DNA sequence, adjuvants and delivery method on integration into host DNA, INTERVIROLO, 43(4-6), 2000, pp. 273-281
Citations number
21
Categorie Soggetti
Microbiology
Journal title
INTERVIROLOGY
ISSN journal
03005526 → ACNP
Volume
43
Issue
4-6
Year of publication
2000
Pages
273 - 281
Database
ISI
SICI code
0300-5526(200007/12)43:4-6<273:PDVTDA>2.0.ZU;2-S
Abstract
A variety of factors could affect the frequency of integration of plasmid D NA vaccines into host cellular DNA, including DNA sequences within the plas mid, the expressed gene product (antigen), the formulation, delivery method , route of administration, and the type of cells exposed to the plasmid. In this report, we examined the tissue distribution and potential integration of plasmid DNA vaccines following intramuscular administration in mice and guinea pigs. We compared needle versus Biojector (needleless jet) delivery , examined the effect of aluminum phosphate adjuvants, compared the results of different plasmid DNA vaccines, and tested a gene (the human papilloma virus E7 gene) whose protein product is known to increase integration frequ ency in vitro. Six weeks following intramuscular injection, the vast majori ty of the plasmid was detected in the muscle and skin near the injection si te; lower levels of plasmid were also detected in the draining lymph nodes. At early time points (1-7 days) after injection, a low level of systemic e xposure could be detected. Occasionally, plasmid was detected in gonads, bu t it dissipated rapidly and was extrachromosomal - indicating a low risk of germline transmission. Aluminum phosphate adjuvant had no effect on the ti ssue distribution and did not result in a detectable increase in integratio n frequency. Biojector delivery, compared with needle injection, greatly in creased the uptake of plasmid (particularly in skin at the injection site), but did not result in a detectable increase in integration frequency. Fina lly, injection of a plasmid DNA vaccine containing the human papilloma viru s type 16 E7 gene, known to increase integration in vitro, did not result i n detectable integration in mice. These results suggest that the risk of in tegration following intramuscular injection of plasmid DNA is low under a v ariety of experimental conditions. Copyright (C) 2001 S. Karger AG, Basel.